Risk Reduction (RR) Chapter
The Prevention Research Synthesis (PRS) Project has been conducting on-going systematic reviews (i.e., Risk Reduction (RR) Efficacy Review ) to identify evidence-based interventions (EBIs) that show evidence of efficacy in changing sex or drug-injection behaviors that directly impact HIV-transmission risk. Additional details about the RR Chapter or PRS can be obtained by contacting PRS.
Updated on March 8, 2019
- Starting in December 2016, Risk Reduction interventions focused on non-priority populations and published over 10 years ago will be archived. Please see the Archived Interventions page for further information.
- Beginning in 2015, PRS will focus only on evaluating RR interventions for priority populations, in line with DHAP’s High-Impact Prevention (HIP) approach. More information about upcoming changes to the PRS RR review process.
NEW Risk Reduction Interventions for 2018 and 2019
- Page last reviewed: March 11, 2019
- Page last updated: March 11, 2019
- Content source: Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention